Press Releases
NUBURU, Inc. and Tailwind Acquisition Corp. Announce Closing of Business Combination
The combined company will operate under the “Nuburu, Inc.” name and its common stock and warrants will commence trading on February 1, 2023
BioSkryb Welcomes Accomplished Genomics Executive Suresh Pisharody as New CEO
Suresh Pisharody brings strong leadership experience honed at Illumina, Thermo Fisher Scientific, and Guardant Health to lead BioSkryb in its next phase of growth
South 8 Technologies Welcomes Battery Energy Storage Systems Expert to its Advisory Board
Yves Saw brings 30 years of experience in R&D, software and battery systems to South 8
MedCrypt Extends Series B with Additional Investment from Dexcom Ventures
These funds will be used to grow MedCrypt’s engineering team in response to an increased demand for encryption and PKI solutions optimized for medical devices
Dennis Fehr, Seasoned Financial Executive Joins 6K as Chief Financial Officer and Rob Davies, Manufacturing Expert, Joins 6K Energy as Chief Operating Officer
New appointments aid in goal of ensuring domestic supply chain of battery materials
Niron Magnetics Appoints Seasoned Innovative Materials Executive Jonathan Rowntree as New CEO
Jonathan Rowntree brings extensive experience in technical advanced materials and commercialization to advance Niron’s scaling and operational capabilities
NUBURU Showcases Compact Blue Laser 3rd Generation Light Engine at PW 2023
New form factor accelerates high brightness integration in industrial fabrication machines
e-Zinc Selected for the 2023 Global Cleantech 100 List
The 2023 Global Cleantech 100 recognizes e-Zinc as one of the exceptional innovators enabling the race to net-zero
U.S. Department of Energy Awards South 8 Technologies $3.152M EVs4ALL Grant
The $3.125 million grant allows South 8 to develop high-power, rapid-charge Li-ion battery cells using its LiGas® electrolyte.
Zeon Corporation Acquires Edge Precision Manufacturing Inc (“Edge”), a leading manufacturer of micro featured thermoplastic devices for diagnostic, clinical, optics, and research applications
Innovative Materials meets High Precision Micro-Manufacturing, Accelerating the Development of Healthcare and Life Sciences Business
InterVenn Biosciences Enters Next Stage with Senior Management Team Updates Focused on Commercialization
Erwin Estigarribia appointed as Chief Executive Officer and Laura Beggrow appointed as Chief Commercial Officer
InterVenn Biosciences to Present at the 41st Annual J.P. Morgan Healthcare Conference on January 11, 2023
InterVenn’s senior management will present at the J.P. Morgan 41st annual Healthcare Conference on January 11, 2023
Azumo Announces 3.4” Memory-in-Pixel (MIP) Reflective LCD Display to Enable Sunlight-Readable, Energy-Efficient Devices
At 272 x 451 pixels, the module is one of the highest-resolution color MIP reflective LCDs of its size
Tailwind Acquisition Corp. and NUBURU, Inc. Announce Stockholder Approval of Business Combination
Tailwind’s shareholders voted to approve the previously announced business combination between Tailwind and NUBURU as well as other proposals related to the business combination.
EnCharge AI Launches with $21.7M Series A to Enable Edge AI at Scale
Following years of research and development at Princeton University, EnCharge AI emerges from stealth led by a world-class, multi-disciplinary team from Meta, NVIDIA, Qualcomm, and IBM.
Niron Magnetics Secures $17.5M SCALEUP Grant from the U.S. Department of Energy’s ARPA-E
Government funding and commercial partnerships further validate the potential of Niron’s Clean Earth Magnet® technology and will accelerate production plans to usher in a more sustainable future
South 8 Technologies Welcomes Intellectual Property Expert to its Board of Director – November 2022
South 8 Technologies welcomes intellectual property expert Andrew Filler to its board of directors.
South 8 Technologies More Than Triples its San Diego Battery Manufacturing and Office Space
Expansion adds a pilot production line for South 8’s unique liquefied gas electrolyte, marketed as LiGas®, for lithium-ion battery manufacturers and end-users seeking safer, higher performance and lower-cost battery-making materials.
InterVenn Biosciences to Participate in Canaccord Genuity’s MedTech, Diagnostics and Digital Health & Services Forum
InterVenn Biosciences announced Company management will present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum in New York on November 17, 2022 at 2:30 p.m. Eastern Time.
Codetta Biosciences and North Carolina Central University Receive $2M Grant from the North Carolina Collaboratory
New funding will allow Codetta and NCCU to advance COVID related research and future clinical care
The U.S. Department of Defense Taps Xendee to Optimize Microgrid Design for Military Installations
Xendee’s integrated platform provides a standardized approach that cuts microgrid design time, slashes engineering expenses, and is scalable across the Department of Defense.
MedCrypt Raises $25M Series B for Continued Growth and Innovation in Medical Device Cybersecurity
MedCrypt will use the funds for the continued delivery of proactive cybersecurity solutions to help medical device manufacturers meet cybersecurity requirements set by the FDA and international regulators
Anzu Partners Named to Inc.’s 2022 List of Founder-Friendly Investors
For the second consecutive year, Inc. recognized Anzu Partners for its commitment to breakthrough technology founders and entrepreneurs
OTI Lumionics Raises $55 Million in Series B Funding and Completes Customer Mass Production Qualification of its Display Materials
The company’s technology enables the front facing camera and other sensors to be integrated under the display, eliminating notches and cut-outs in mobile devices screens
Erwin Estigarribia is Appointed President and Chief Operating Officer of InterVenn Biosciences
InterVenn is focusing on the development and commercialization of its Advanced Adenoma and Colorectal Cancer screening platform to change the paradigm for the detection of early-stage disease
AM Batteries (AMB) Secures $25M Series A Financing to Scale Manufacturing of Novel Lithium-Ion Dry-Electrode Technology
AM Batteries (AMB) is a Boston-based innovative manufacturing company developing a next-generation, lower-carbon footprint and lower cost dry-electrode manufacturing technology for lithium-ion batteries
Xendee Microgrid Design Platform Adds New Feature to Help Engineers Take Advantage of Inflation Reduction Act Incentives
Xendee platform now offers tools to apply these incentives directly to the technologies during the modeling process.
Excision BioTherapeutics to Host Key Opinion Leader Webinar on HIV and the Ongoing Phase 1/2 Trial Evaluating EBT-101 as a Potential Cure
Webinar will focus on the unmet medical need in HIV, therapeutic applications of gene delivery and editing for treatment of viral disease, and the Company’s ongoing Phase 1/2 trial evaluating the CRISPR-based therapy, EBT-101, as a treatment for HIV
6K Awarded Prestigious Department of Energy Grant to Fund $107M UniMelt Plasma Processing Plant for Domestic Battery Material Production
The new plant will demonstrate the ability to domestically produce multiple battery chemistries in the same
factory with the capacity of 3,000 tons per annum (tpa) in 2025 scaling to 10,000 tpa in 2026
BioSkryb Genomics and Cooper Surgical Ink Multi-Year Deal to Accelerate Clinical Discovery and Diagnostics in Women’s Reproductive Health
New partnership brings transformative, high-resolution single-cell genomic technology to the field of preimplantation genetic testing in the pursuit of improved discovery and clinical outcomes.
e-Zinc Works with Silicon Valley Bank and Secures USD $7 Million Venture Debt Facility
The funding will be used to expand production at e-Zinc’s new Mississauga, ON facility and accelerate commercialization efforts
e-Zinc CEO James Larsen Named to Canada’s 2023 Clean50
e-Zinc announced that its CEO James Larsen was named one of Canada’s 2023 Clean50 in the research and development category.
InterVenn Biosciences Co-Founder Carolyn Bertozzi Awarded Nobel Prize in Chemistry
InterVenn Biosciences announced that its co-founder Carolyn Bertozzi, Ph.D., has been awarded the 2022 Nobel Prize in chemistry.
InterVenn Biosciences Expands Board of Directors with Dr. Jason Myers and Carol Berry to Support Next Phase of Growth
InterVenn Biosciences announced the appointment of Jason Myers, Ph.D., and Carol Berry to the company’s Board of Directors.
Excision BioTherapeutics Awarded California Institute for Regenerative Medicine (CIRM) Grant to Support Ongoing Phase 1/2 Trial Evaluating EBT-101 as a Potential Cure for HIV
CIRM Grant of $6.85 million supports the first-in-human clinical study evaluating the safety and efficacy of EBT-101 in participants people living with HIV
Xendee Integrates UtilityAPI for Easier, Faster and More Precise Energy Load Modeling
The integration maximizes the efficiency of downloading past building load data directly from the utility, which gives engineers a more accurate view of past usage and peak requirements of their project.
Niron Magnetics Expands Management Team with Three Key Technology and Operations Hires
Experts in materials science, engineering, and operations will help Niron commercialize the world’s first high performance rare-earth free permanent magnets
Anzu Partners Welcomes Donald Rosenberg as Venture Partner
Rosenberg will work with portfolio companies as they develop their intellectual property strategies and more broadly support the next generation of transformative technology companies.
BioXpedia A/S and BioSkryb Genomics Announce European Partnership to Provide Groundbreaking, Single-Cell, Multiomic Analysis for Novel Target Identification and Therapeutic Development
This new partnership brings high-resolution, single-cell whole genome and whole transcriptome analysis to Europe. This partnership will enable novel insights and deep cellular characterization required in the evaluation, creation, and validation of new generation biologics and therapeutics in targeted disease management.
Introducing the GelSight Mini: A Human Resolution Tactile Sensor for Engineers and Scientists
GelSight Mini enables an enhanced AI-enabled tactile experience for users in just five minutes out of the box.
ImmunoScape Raises $14M to Facilitate the Discovery and Characterization of Cancer-Specific T-Cell Receptors
ImmunoScape, a pre-clinical biotechnology company focused on the discovery and development of next-generation TCR-T-cell therapeutics announced that it has raised $14M in new financing.
Xendee Releases New Features for Effectively Designing Sustainable Communities, Large Facilities, and Utility-Scale Microgrids
Xendee’s optimization software even takes into account cable length, losses through transferring energy, and the most efficient ways to generate and distribute energy from multiple energy sources at all hours of the day.
Excision BioTherapeutics Doses First Participant in EBT-101 Phase 1/2 Trial Evaluating EBT-101 as a Potential Cure for HIV
Excision BioTherapeutics announced that the first participant has been dosed in the Phase 1/2 clinical trial of EBT-101 for human immunodeficiency virus type 1 (HIV-1).
ImmunoScape To Present at the 7th Annual CAR-TCR Summit
ImmunoScape announced that Dan MacLeod, Ph.D., the company’s vice president of discovery, will present at the 7th Annual CAR-TCR Summit taking place September 19-22, 2022 in Boston.
Liquid Instruments Raises $28.5 Million to Revolutionize Technology Development with Software-Defined Test Instrumentation
Growth investment accelerates product innovation, talent acquisition and expansion in commercial, educational markets
Excision BioTherapeutics to Present at Upcoming Conferences
Excision BioTherapeutics Inc. announced that Excision Management will present at the following upcoming investor conferences.
6K Additive Reduces Material Cost, Recycles Metal Powder and Secures Domestic AM Metal Supply for Incodema3D
6K Additive produced from its UniMelt® plasma technology, announces a strategic AM powder supply agreement and recycling partnership with Freeville, NY-based Incodema3D.
Introducing Voltaiq Community Edition
An open-access Battery Intelligence platform to analyze batteries, build models and algorithms, collaborate and share insights
InterVenn Biosciences to Present at the 20th Annual Morgan Stanley Global Healthcare Conference
Aldo Carrascoso, Co-Founder and CEO, and Erwin Estigarribia, COO, will present at the 20th Annual Morgan Stanley Global Healthcare Conference on Tuesday, September 13, 2022 in New York, NY
Nature’s Toolbox Names Yesim Roth as Chief Financial Officer
Seasoned CFO joins NTx with deep global experience in building financial systems for startups, venture capital, and investor relations
Search
Latest Media Coverage
OLED Display’s Impact on Battery Life for Consumer Tech Devices
AV+ Podcast: Supply-Chain Forecast & Potential Solutions for Vendors
The drive for innovation often hits speed bumps
AI chip startup EnCharge AI raises $21.7M to build integrated stack for edge uses
EnCharge AI, a chip startup born in Princeton lab, raises $21.7 mln
EnCharge AI emerges from stealth with $21.7M to develop AI accelerator hardware
Special report: Meet 20 women blazing trails in biopharma R&D